Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.

Taccone, Fabio S; Gorham, Julie; Vincent, Jean-Louis

Taccone, Fabio S; Gorham, Julie; Vincent, Jean-Louis.

Taccone FS; Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Gorham J; Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Vincent JL; Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, 1070 Brussels, Belgium. Electronic address: jlvincent@intensive.org.

Lancet Respir Med ; 8(6): 539-541, 2020 06.

Article in English | MEDLINE | ID: covidwho-60313

Subject(s)

Coronavirus Infections/drug therapy; Drug Repositioning; Evidence-Based Medicine; Hydroxychloroquine/therapeutic use; Pneumonia, Viral/drug therapy; Betacoronavirus; COVID-19; Coronavirus Infections/virology; Health Services Needs and Demand; Humans; Pandemics; Pneumonia, Viral/virology; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Evidence-Based Medicine / Drug Repositioning / Hydroxychloroquine Limits: Humans Language: English Journal: Lancet Respir Med Year: 2020 Document Type: Article Affiliation country: S2213-2600(20)30172-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google